Clearside Biomedical, Inc.
SEC CIK 1539029 · CLSD · last insider filing 2025-02-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Thorp Clay | Director | filed 2016 - 2025 |
| Lasezkay George M | Director · Interim CEO | filed 2017 - 2025 |
| Yerxa Benjamin R | Director | filed 2022 - 2024 |
| Shaffer Christy L | Director | filed 2016 - 2024 |
| Edwards Jeffrey L | Director | filed 2018 - 2024 |
| Hutson Nancy J | Director | filed 2020 - 2024 |
| Croarkin Richard | Director | filed 2016 - 2024 |
| Humphries William D. | Director | filed 2016 - 2024 |
| Gibney Anthony S | Director | filed 2024 - 2024 |
| White Daniel H. | Director · President and CEO | filed 2016 - 2019 |
| Cagle Gerald D. | Director | filed 2016 - 2018 |
| Zaytsev Evgeny | Director | filed 2016 - 2018 |
| Yoon Derek | Director | filed 2016 - 2017 |
| Chen Bihua | Director | filed 2016 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Deignan Charles A. | Chief Financial Officer | filed 2016 - 2025 |
| Chong Ngai Hang Victor | Chief Medical Officer | filed 2024 - 2025 |
| Ciulla Thomas | Chief Medical Officer | filed 2020 - 2023 |
| Raymond Brion S. | Chief Commercial Officer | filed 2018 - 2019 |
| Noronha Glenn | Executive Vice President, R&D | filed 2016 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.